Literature DB >> 16953060

ALK7 is a novel marker for adipocyte differentiation.

Masahiro Kogame1, Shinji Matsuo, Masashi Nakatani, Akira Kurisaki, Hiromu Nishitani, Kunihiro Tsuchida, Hiromu Sugino.   

Abstract

Transforming growth factor-beta (TGF-beta) family members regulate a variety of cellular functions and play important roles in cell differentiation. Activin receptor-like kinase 7 (ALK7), a receptor for TGF-beta family members, was initially cloned from rats as an orphan receptor and has been recently shown to be a type I receptor for nodal, activin B and activin AB. ALK7 is expressed not only in neurons, but also in insulin-producing islet beta cells and white and brown adipose tissues; however, the specific functions of ALK7 in these tissues are not known. In order to test whether ALK7 is involved in adipocyte differentiation, we analyzed its expression during adipocyte differentiation. ALK7 expression was detected in the late phase of adipocyte differentiation by reverse transcriptase-polymerase chain reaction (RT-PCR), Western blotting and immunofluorescence staining in 3T3-L1 cells. We also detected the expression of ALK7 by RT-PCR in stromal vascular fraction (SVF) cells. These results indicated that ALK7 is a novel marker specifically expressed during the late phase of adipocyte differentiation. Furthermore, our results suggest the possible involvement of nodal or activin B in adipocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16953060     DOI: 10.2152/jmi.53.238

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  15 in total

Review 1.  Activins and Inhibins: Roles in Development, Physiology, and Disease.

Authors:  Maria Namwanje; Chester W Brown
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

Review 2.  Emerging roles for the transforming growth factor-{beta} superfamily in regulating adiposity and energy expenditure.

Authors:  Nader Zamani; Chester W Brown
Journal:  Endocr Rev       Date:  2010-12-20       Impact factor: 19.871

3.  Nodal induces apoptosis through activation of the ALK7 signaling pathway in pancreatic INS-1 β-cells.

Authors:  Fang Zhao; Fengjie Huang; Mengxiong Tang; Xiaoming Li; Nina Zhang; Akis Amfilochiadis; Yiming Li; Renming Hu; Tianru Jin; Chun Peng; Qinghua Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-05-01       Impact factor: 4.310

4.  The orphan ligand, activin C, signals through activin receptor-like kinase 7.

Authors:  Erich J Goebel; Luisina Ongaro; Emily C Kappes; Kylie Vestal; Elitza Belcheva; Roselyne Castonguay; Ravindra Kumar; Daniel J Bernard; Thomas B Thompson
Journal:  Elife       Date:  2022-06-23       Impact factor: 8.713

5.  Bone Marrow Adiposity in Models of Radiation- and Aging-Related Bone Loss Is Dependent on Cellular Senescence.

Authors:  Abhishek Chandra; Anthony B Lagnado; Joshua N Farr; Megan Schleusner; David G Monroe; Dominik Saul; João F Passos; Sundeep Khosla; Robert J Pignolo
Journal:  J Bone Miner Res       Date:  2022-03-29       Impact factor: 6.390

6.  ALK7 Acts as a Positive Regulator of Macrophage Activation through Down-Regulation of PPARγ Expression.

Authors:  Wen-Lin Cheng; Quan Zhang; Jian-Lei Cao; Xi-Lu Chen; Wenyan Li; Lin Zhang; Sheng-Ping Chao; Fang Zhao
Journal:  J Atheroscler Thromb       Date:  2020-07-09       Impact factor: 4.928

7.  Activin receptor-like kinase 7 suppresses lipolysis to accumulate fat in obesity through downregulation of peroxisome proliferator-activated receptor γ and C/EBPα.

Authors:  Satomi Yogosawa; Shin Mizutani; Yoshihiro Ogawa; Tetsuro Izumi
Journal:  Diabetes       Date:  2012-08-28       Impact factor: 9.461

8.  Activin signaling as an emerging target for therapeutic interventions.

Authors:  Kunihiro Tsuchida; Masashi Nakatani; Keisuke Hitachi; Akiyoshi Uezumi; Yoshihide Sunada; Hiroshi Ageta; Kaoru Inokuchi
Journal:  Cell Commun Signal       Date:  2009-06-18       Impact factor: 5.712

9.  ALK7 expression is specific for adipose tissue, reduced in obesity and correlates to factors implicated in metabolic disease.

Authors:  Lena M S Carlsson; Peter Jacobson; Andrew Walley; Philippe Froguel; Lars Sjöström; Per-Arne Svensson; Kajsa Sjöholm
Journal:  Biochem Biophys Res Commun       Date:  2009-03-09       Impact factor: 3.575

10.  ALK7 gene polymorphism is associated with metabolic syndrome risk and cardiovascular remodeling.

Authors:  Wenchao Zhang; Hui Wang; Wei Zhang; Ruijuan Lv; Zhihao Wang; Yuanyuan Shang; Yun Zhang; Ming Zhong; Yuguo Chen; Mengxiong Tang
Journal:  Arq Bras Cardiol       Date:  2013-06-14       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.